News

Embryonic-like stem cells can be efficiently generated using a natural signaling molecule instead of the virally delivered cancer-causing gene c-Myc.

The first large-scale study of the protein output of genes targeted by microRNAs confirms that each microRNA adjusts the production of many proteins, and sheds important light on how this regulation occurs.

Whitehead Member Peter Reddien has been named one of five Distinguished Young Scholars in Medical Research by the W.M. Keck Foundation.

Whitehead Director David Page shares thoughtful reflection upon the passing of Institute Board member Alex d'Arbeloff.

Cells from mice created using genetically reprogrammed cells can be triggered via drug to enter an embryonic stem-cell-like state.

Whitehead Member Susan Lindquist has been awarded a Graduate School of Arts and Sciences (GSAS) Centennial Medal from Harvard University, given annually to graduate alumni who have made exceptional contributions to society.

Sabatini has been appointed a Howard Hughes Medical Investigator, a highly sought-after post that recognizes the nation’s top biomedical scientists.

Improved understanding of this nutrient-sensing pathway may aid in developing therapies for cancer and diabetes.

Understanding the role of EMT in adult stem cell creation may lead toward the development of healthy stem cells for regenerative medicine and provide drug targets for cancer.

Fully differentiated cells can be reprogrammed to induced pluripotent stem (IPS) cells.